A carregar...
Interleukin-17 promotes the development of cisplatin resistance in colorectal cancer
Cisplatin (DDP)-based anticancer therapy is an important chemotherapeutic strategy for the treatment of colorectal cancer. However, its beneficial effect is largely compromised by adverse reactions, and more importantly, by the development of drug resistance. Therefore, it is crucial to determine th...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313016/ https://ncbi.nlm.nih.gov/pubmed/30655852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9645 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|